期刊文献+

免疫透射比浊法测定血清轻链

Measurement of Serum Light Chain with Immunoturbidimetry
下载PDF
导出
摘要 目的:评价采用免疫透射比浊法检测血清轻链的可行性。方法:在贝克曼CX4全自动生化分析仪上,应用ROCHE公司试剂,以免疫透射比浊法,采用二点终点法,主波长340nm,副波长700nm,温度37℃,六点校准。结果:本法检测kappa轻链,日内不精密度2.5~2.8,日间不精密度3.0~3.2,检测低限为0.19g/L,回收率为92.1~101.5,检测lambda轻链,日内不精密度1.6~1.8,日间不精密度2.2~2.5,检测低限为0.16g/L,回收率为94.2~102.5,免疫透射比浊法(Y)与贝克曼IMAGE特定蛋白分析仪的免疫散射比浊法(X)比较:kappa轻链Y=0.265X-0.232。决定系数(r2)=0.957,lambda轻链Y=0.438X-0.03。决定系数(r2)=0.976。结论:免疫透射比浊法简便,灵敏,试剂稳定,适合一般医院血清轻链的自动化分析。 Objective To evaluate the feasibility of measuring serum light chain concentration with immunoturbidimetry. Methods Immunoturbidimetry (with Roche reagent) was carried out with two- point endpoint method (first wavelength and second wave- length were 340nm and 700nm respectively running at 37℃, combining with six - point calibration). Results For kappa, chain the within - run coefficien of variation(CV) was 2.5-2.8%, the between - run CV was 3.0-3.2%, the lower limit of detection was 0.19g/L, the recovery rate was 92.1 N 101.5% , For lambda chain the within - run coefficien of variation(CV) was 1.6 - 1.8% , the between- run CV was 2.2 -2.5% , the lower limit of detection was 0.16g/L, the recovery rate was 94.2-102.5% , Compared with the conventional immunoseatteringmetry ( Beckman IMAGE analyzer) , the correlation equation was : for kappa Y=0.265X-0.232, coefficient eorrelation(r^2) was 0.957, for lambda Y=0.438X-0.03 coefficient eorrelation(r^2) was 0.976. Conclusion The Roche immunoturbidimetry is convenient, sensitive and stable and is suitable to routine application for automatic measurement of serum fight chain concentration.
作者 卢琦 陈金锦
出处 《放射免疫学杂志》 CAS 2008年第6期583-585,共3页 Journal of Radioimmanology
关键词 轻链 透射比浊法 散射比浊法 全自动生化分析仪 light chain, turbidimetry, scatteringmetry, automatic biochemistry analyzer
  • 相关文献

参考文献3

二级参考文献20

  • 1[1]Davenport JM,Schlain B.Testing claimed minimal detectable concentrations of in vitro medical diagnostic devices[J].Clin Chem,2000,46:1669-1680.
  • 2[2]Diamandis EP,Yu J,Melegos DN.Ultrasensitive Prostate-specific antigen assaya and their clinical application[J].Clin Chem,l996,42:853-857.
  • 3[3]Stamey TA.Lower lin\mits of detection,Biological detection limits,functional sensitivity,or residual cancer detection? Sensitivity report on Prostate-specific antigen assays mislead clinicians[J].Clin Chem,1996,42:849-852.
  • 4Abe M, Goto T, osaka MK, et al. Differences in kappa to lambda(κ:λ)ratios of serum and urinary free light chains[J]. Clin Exp Immunol,1998,111:457-462.
  • 5Imoto M, Ishikawa K, Yamamoto K, et al. A Case of multiple myeloma IgG(λ) type with low molecular weight κ light chain[J].Clin Chim Act, 1998,277: 99-105.
  • 6张秀梅 李立 刘学明 等.轻链病9例报告[J].中华血液学杂志,1987,8(10):594-595.
  • 7Morie AG, Martha QL, John A, et al. Phase Ⅱ trail of high-dose dexamethasone for previously treated immunoglobulin light-chain amyloidosis[J]. Am J Hematol, 1999,61:115-119.
  • 8Levinson SS. Kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias[J]. Clin Chem, 1991,37(6): 1122-1126.
  • 9Kathleen JW, Gerald G, Guillermo AH, et al. Cardiac amyloidoma with IgM-κ gammopathy[J]. Arch Pathol Lab Med, 1994,118:1148-1150.
  • 10Stevenson FK, Speelerberg M and Smith JL. Monoclonal immunoglobin light chain in urine of patients with B lymphocytic disease:its source and use as a diagnostic aid[J].Br J Cancer, 1983,47:607-612.

共引文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部